Literature DB >> 19995755

The pro and anti-inflammatory activities of immunoglobulin G.

A Lux1, S Aschermann, M Biburger, F Nimmerjahn.   

Abstract

Immunoglobulin G (IgG) molecules are a family of glycoproteins essential for defending the body against invading pathogens. The antibody constant domain is very potent in initiating proinflammatory pathways such as the activation of innate immune effector cells via cellular receptors specific for the antibody constant region (Fc receptors) and the activation of the complement pathway. During autoimmune disease the normally protective antimicrobial function of these molecules is targeted to healthy tissues often with disastrous consequences. Interestingly, one successful anti-inflammatory therapy for many autoimmune diseases is the infusion of high doses of IgG molecules, the so-called intravenous IgG therapy. How one class of molecules can have such opposing functions will be the major focus of this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19995755     DOI: 10.1136/ard.2009.117101

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes.

Authors:  Irina Perdivara; Shyamal D Peddada; Frederick W Miller; Kenneth B Tomer; Leesa J Deterding
Journal:  J Proteome Res       Date:  2011-06-08       Impact factor: 4.466

2.  Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.

Authors:  Maurílio F Santos; Roger R C New; Gabrielle R Andrade; Christiane Y Ozaki; Osvaldo A Sant'Anna; Lucia Mendonça-Previato; Luis R Trabulsi; Marta O Domingos
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

Review 3.  Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Authors:  Jacqueline M Achkar; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

Review 4.  Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

5.  Different effects of global osteopontin and macrophage osteopontin in glomerular injury.

Authors:  Jessica Trostel; Luan D Truong; Carlos Roncal-Jimenez; Makoto Miyazaki; Shinobu Miyazaki-Anzai; Masanari Kuwabara; Rachel McMahan; Ana Andres-Hernando; Yuka Sato; Thomas Jensen; Miguel A Lanaspa; Richard J Johnson; Gabriela E Garcia
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-02

Review 6.  Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship.

Authors:  Giada Rossini; Cristina Cerboni; Angela Santoni; Maria Paola Landini; Santo Landolfo; Deborah Gatti; Giorgio Gribaudo; Stefania Varani
Journal:  Mediators Inflamm       Date:  2012-05-31       Impact factor: 4.711

7.  Retinal glycoprotein enrichment by concanavalin a enabled identification of novel membrane autoantigen synaptotagmin-1 in equine recurrent uveitis.

Authors:  Margarete E Swadzba; Stefanie M Hauck; Hassan Y Naim; Barbara Amann; Cornelia A Deeg
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

8.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07

9.  Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.

Authors:  Maria L Knudsen; Karl Ljungberg; Roger Tatoud; Jonathan Weber; Mariano Esteban; Peter Liljeström
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

10.  Autoantibodies targeting tumor-associated antigens in metastatic cancer: Sialylated IgGs as candidate anti-inflammatory antibodies.

Authors:  Martin Oaks; Samuel Taylor; James Shaffer
Journal:  Oncoimmunology       Date:  2013-05-07       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.